维普中文期刊产品整合服务
75篇 您的检索式:作者名="Fedi S"
    题名 作者 年代 出处 被引量
1显示文摘Fedi S Soft F Brogi D 2003Thromb Haemost2003,90,6:1
2High prevalence of mild hyperhomoeysteinemia in patients with abdominal aortic aneurysm显示文摘Brunelli T Priseo D Fedi S 2000J Vase Surg2000,32,3:1
3Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischemic heart diseases patients显示文摘Falciani M Gori AM Fedi S 1998Thromb Haemost1998,79,:1
4tissue factor and tissue factor pathway inhibitor levels in unstable angina patients during short-term lowmolecular-weight heparin administration显示文摘Gori AM Fedi S Pepe G 2002Br J Haematol2002,117,3:1
5CD enhanced solubilization and aerobic biodegradation of PCB in two aged-contamina- ted soils 显示文摘Fava F Bertin L Fedi S 2003Biotechnology and Bioengineering2003,81,:1
6Low protein Z plasma levels are independently associated with acute coronary syndromes 显示文摘Fedi S Soft F Bmgi D 2003Thromb naemost2003,90,6:1
7Tissue factor and tissue factor pathway inhibitor levels in unstable angina patients during short - term low - molecular - weight heparin administration 显示文摘Cori AM Fedi S Pepe G 2002Br J Haematol2002,117,3:1
8Methyl-β-cyclodextrin-enhanced solubilization and aerobic biodegradation of polychlorinated biphenyls in two aged-contaminated soils显示文摘Fava F Bertin L Fedi S 2003Biotechnology & Bioengineering2003,81,4:1
9Self expandable metal stent as bridge-t:surgery in acute bowel obstruction显示文摘Giannessi S Paroli GM Fedi M 2013Minerva Chir2013,68,3:1
10High prevalence of mild hyperhomocysteinemia in patients with abdominal aortic aneurysm 显示文摘Brunelli T Prisco D Fedi S 2000J Vase Surg2000,32,:1
11Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients 显示文摘Falcmani M Gori AM Fedi S 1998Thromb Haemost1998,79,:1
12T - RFLP analysis of bacterialcommunities in cyclodextrin - amended bioreactors developed forbiodegradation of polychlorinated biphenyls 显示文摘Fedi S Tremaroli V Scala D 2005Research inMicrobiology2005,156,2:1
13Thromhophilic risk factors in patientswith severe carotid atheroselerosis 显示文摘Marcucci R Soft F Fedi S 2005J Thromb Haemost2005,3,3:1
14Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients显示文摘Falciani M Gori AM Fedi S 1998Thromb Haemost1998,79,3:1
15Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients 显示文摘 Gori AM Fedi S 1998Thromb Haemost1998,79,3:1
16Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients显示文摘Falciani M Gori A M Fedi S 1998Thromb Haemost1998,79,3:1
17Tissue factor and tissue factor pathway inhibitor levels in unstable angina patients during short-term low-molecular-weight heparin administration显示文摘Gori AM Fedi S Pepe G 2002Br J Haematol2002,117,3:1
18Modifications of protein Z and interleukin-6 during the acute phase of coronary artery disease显示文摘Cesari F Gori S Fedi S 2007Blood Coagul Fibrinolysis2007,18,1:1
19Hypercoagulability, hightissue factor and low tissue factor pathway inhibitor levels in se-vere ovarian hyperstimulation syndrome: possible associationwith clinical outcome显示文摘Rogolino A Coccia ME Fedi S 2003Blood Coagulation Fibrinolysis2003,14,3:1
20Modifications of protein Z and interleukin-6 during the acute phase of coronary artery disease显示文摘Cesari F Gori AM Fedi S 2007Blood Coagul Fibrinolysis2007,18,1:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费